Clinical Trial

Diabetes Foot Africa Region Registry

Study acronym: (D-FAR)
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
D-FAR is to gather robust data on the clinical characteristics, management, and outcomes of patients with diabetic foot complications to enhance understanding, reduce complications, and improve patient care. This will include insights into the prevalence of risk factors, adherence to treatment protocols, and the effectiveness of interventions aimed at reducing the incidence of amputations and other adverse outcomes.
Trial Details
NCT Number NCT07031141
Lead Sponsor Getz Pharma
Conditions Diabetes
Enrollment 2,000 participants
Start Date 2025-08-01
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-22